ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Sanofi Complete list of announcements declared & dividend announcements by Sanofi GCVRZ

Sanofi GCVRZ listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sanofi GCVRZ

Sanofi introduces diabetes drug Soliqua in India
Sanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and GLP-1 receptor agonist lixisenatide. The medication is available at a therapy cost of Rs 1,850 per pen and is indicated for adults
Announcement as on 30 April 2024

Sanofi eyes speedy growth in India, plans fast-tracking of product pipeline
Aiming for a "fair share" in the Indian pharmaceutical market, French drug major Sanofi plans to introduce new drugs and enhance localisation while expanding the reach of its existing brands through collaboration with domestic drug firms, according to a to
Announcement as on 07 April 2024

Sanofi looks for accelerated growth in India; plans fast-tracking of product pipeline
Sanofi, a leading French pharmaceutical company, aims to expand its presence in the Indian market by introducing new drugs, enhancing localization efforts, and collaborating with domestic firms. Managing Director Rodolfo Hrosz highlights the significant gr
Announcement as on 07 April 2024

Sanofi gets nod for new polio vaccine in India
To ensure that there is no interruption to the availability of IPV vaccines, the French firm has already obtained approvals for IMOVAX-Polio.
Announcement as on 05 April 2024

Sanofi gets nod for injectable Polio vaccine
​​The announcement comes a day after ET reported that the company had ceased production of its ShanIPV vaccines in India, which may lead to a potential shortage in the country.
Announcement as on 05 April 2024

Announcements by Sanofi first page | Next page | Prev page |

GCVRZ Sanofi current price & indicator signals

Moving Averages for Sanofi

  • 5Day Average: 0.87
  • 12Day Average: 0.87
  • 20Day Average: 0.87
  • 50Day Average: 0.87
  • 100Day Average: 0.83
  • 150Day Average: 0.73
  • 200Day Average: 0.68

GCVRZ Indicators & signals

Indicator MACD (12,26,9)

0.84, 0.81, 0.05
Indicator MACD is in positive zone

Indicator ADX (14)

0, 28.57, 28.57
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 64
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GCVRZ Sanofi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Tue Mar 2020 0.87 0.87 to 0.88 0% 18.75 times
02 Mon Mar 2020 0.87 0.87 to 0.87 0% 0.55 times
28 Fri Feb 2020 0.87 0.87 to 0.88 0% 1.5 times
27 Thu Feb 2020 0.87 0.87 to 0.88 0% 5.49 times
26 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.2 times
25 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.24 times
24 Mon Feb 2020 0.87 0.86 to 0.87 0% 0.57 times
21 Fri Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
20 Thu Feb 2020 0.87 0.87 to 0.87 0% 0.09 times
19 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.28 times
18 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
17 Mon Feb 2020 0.87 0.87 to 0.87 0% 0 times

Videos related to: GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

 

Back to top